MRSN
Mersana Therapeutics Inc.
$7.40
+$0.04(+0.61%)
25
Overall
--
Value
25
Tech
--
Quality
Market Cap
$35.98M
Volume
60.84K
52W Range
$5.21 - $70.75
Target Price
$28.29
EPS Estimates Overview
| Current Quarter | $-1.44 | Next Quarter | $-2.16 |
| Current Year | $-1.07 | Next Year | $-6.42 |
| QoQ Growth | -50.0% | YoY Growth | -500.0% |
| 3Y EPS CAGR | +79.0% | Target Price | $28.29 |
| Consensus | Buy | Upside | +282.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MRSN | $7.40 | +0.6% | 60.84K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mersana Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW